Related Experiment Videos
Co-trimoxazole-induced hepatic injury--an analysis of cases with hypersensitivity-like reactions
1Department II, Medical Clinic, University of Tübingen.
Abstract:
Trimethoprim-sulfamethoxazole (co-trimoxazole) is used extensively for treatment of pulmonary and urinary tract infections. Side effects may affect skin, blood, bone marrow, kidney and the liver. Although a number of sulfonamides have been reported to have produced hepatic lesions, hepatitis following therapy with trimethoprim-sulfamethoxazole is a rather rare event. While trimethoprim has not yet been reported as a cause of hepatic disorders, sulfamethoxazole has occasionally been described as inducing hepatic injury. In some cases, these reactions are accompanied by symptoms indicative for allergic reactions such as fever, rash and eosinophilia. Seven well documented cases are analyzed and discussed with respect to the nature of side effects caused by co-trimoxazole.
Insights
Trimethoprim-sulfamethoxazole (co-trimoxazole) can cause rare liver injury, sometimes with allergic symptoms. This analysis discusses seven cases of co-trimoxazole-induced hepatic side effects.
Area of Science:
- Pharmacology
- Hepatology
- Infectious Diseases
Background:
- Trimethoprim-sulfamethoxazole (co-trimoxazole) is a widely used antibiotic for treating pulmonary and urinary tract infections.
- While generally safe, potential side effects can impact various organs, including the liver.
Observation:
- Hepatitis associated with co-trimoxazole therapy is considered a rare adverse event.
- Sulfamethoxazole, a component of co-trimoxazole, has been occasionally implicated in inducing hepatic injury.
- Observed reactions can present with allergic symptoms like fever, rash, and eosinophilia.
Findings:
- This study analyzes seven well-documented cases of hepatic side effects attributed to co-trimoxazole.
- The findings explore the nature and characteristics of these rare drug-induced liver injuries.
Implications:
- Understanding these rare hepatic reactions is crucial for clinicians prescribing co-trimoxazole.
- Awareness of potential liver injury and associated allergic symptoms can aid in timely diagnosis and management.
- Further research may elucidate the mechanisms behind co-trimoxazole-induced hepatotoxicity.